Cargando…

Creation of a new class of radiosensitizers for glioblastoma based on the mibefradil pharmacophore

Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous system with a dismal prognosis. Locoregional failure is common despite high doses of radiation therapy, which has prompted great interest in developing novel strategies to radiosensitize these cancers. Our group pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paradkar, Sateja, Herrington, James, Hendricson, Adam, Hewawasam, Piyasena, Plummer, Mark, Hoyer, Denton, Sundaram, Ranjini K., Surovtseva, Yulia V., Bindra, Ranjit S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092340/ https://www.ncbi.nlm.nih.gov/pubmed/33953843 http://dx.doi.org/10.18632/oncotarget.27933

Ejemplares similares

Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma
por: Ganesa, Sachita, et al.
Publicado: (2022)

Mibefradil reduces blood glucose concentration in db/db mice
por: Lu, Yujie, et al.
Publicado: (2014)

Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity
por: Garbarino, Jennifer, et al.
Publicado: (2021)

Prevention of Lens Epithelial Cell Growth In Vitro Using Mibefradil-Containing PLGA Micro Particles
por: Weidmann, Arne, et al.
Publicado: (2008)

Mibefradil alters intracellular calcium concentration by activation of phospholipase C and IP(3) receptor function
por: Souza Bomfim, Guilherme H., et al.
Publicado: (2021)

Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors
por: Sule, Amrita, et al.
Publicado: (2021)

Mibefradil and Flunarizine, Two T-Type Calcium Channel Inhibitors, Protect Mice against Lipopolysaccharide-Induced Acute Lung Injury
por: Wan, Limei, et al.
Publicado: (2020)

Radioresistance in Glioblastoma and the Development of Radiosensitizers
por: Ali, Md Yousuf, et al.
Publicado: (2020)

Structural Insights into the Interaction of Cytochrome P450 3A4 with Suicide Substrates: Mibefradil, Azamulin and 6′,7′-Dihydroxybergamottin
por: Sevrioukova, Irina F.
Publicado: (2019)

A new class of radiosensitizers for glioblastoma
por: Abounader, Roger, et al.
Publicado: (2021)

T-type calcium channel antagonists, mibefradil and NNC-55-0396 inhibit cell proliferation and induce cell apoptosis in leukemia cell lines
por: Huang, Weifeng, et al.
Publicado: (2015)

The radiosensitivity index predicts for overall survival in glioblastoma
por: Ahmed, Kamran A., et al.
Publicado: (2015)

Notch1 ablation radiosensitizes glioblastoma cells
por: Han, Na, et al.
Publicado: (2017)

Novel Strategies for Nanoparticle-Based Radiosensitization in Glioblastoma
por: Ruiz-Garcia, Henry, et al.
Publicado: (2021)

Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers
por: Zoi, Vasiliki, et al.
Publicado: (2022)

Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme
por: Lickliter, Jason D., et al.
Publicado: (2023)

Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization
por: Rath, Barbara H, et al.
Publicado: (2015)

Ca(V)3.2 T-Type Calcium Channels in Peripheral Sensory Neurons Are Important for Mibefradil-Induced Reversal of Hyperalgesia and Allodynia in Rats with Painful Diabetic Neuropathy
por: Obradovic, Aleksandar Lj., et al.
Publicado: (2014)

Expression of TMEM59L associated with radiosensitive in glioblastoma
por: Gao, Dezhi, et al.
Publicado: (2023)

Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma
por: Tsigelny, Igor F., et al.
Publicado: (2015)

Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy
por: Gal, Omer, et al.
Publicado: (2022)

The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells
por: Rezaei, Narges, et al.
Publicado: (2020)

Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma
por: Degorre, Charlotte, et al.
Publicado: (2021)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
por: Miles, Xanthene, et al.
Publicado: (2021)

Molecular sampling of the allosteric binding pocket of the TSH receptor provides discriminative pharmacophores for antagonist and agonists
por: Hoyer, Inna, et al.
Publicado: (2013)

Transcription-independent role for human mitochondrial RNA polymerase in mitochondrial ribosome biogenesis
por: Surovtseva, Yulia V., et al.
Publicado: (2013)

Topological pharmacophores: pros & cons of QSARs based on 2D pharmacophore fingerprints
por: Horvath, D
Publicado: (2008)

Search for the Pharmacophore of Histone Deacetylase Inhibitors Using Pharmacophore Query and Docking Study
por: Haji Agha Bozorgi, Atefeh, et al.
Publicado: (2014)

Ligand-Based Pharmacophore Modeling Using Novel 3D Pharmacophore Signatures
por: Kutlushina, Alina, et al.
Publicado: (2018)

Dual Functional Mesoporous Silicon Nanoparticles Enhance the Radiosensitivity of VPA in Glioblastoma()
por: Zhang, Hailong, et al.
Publicado: (2017)

Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma
por: Li, Junyang, et al.
Publicado: (2018)

New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity
por: Henry, Aurélie, et al.
Publicado: (2016)

Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage
por: Frosina, Guido, et al.
Publicado: (2019)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
por: Choi, Jinyeong, et al.
Publicado: (2020)

The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review
por: Pepper, Niklas Benedikt, et al.
Publicado: (2022)

DNMT3A co-mutation in an IDH1-mutant glioblastoma
por: Fomchenko, Elena I., et al.
Publicado: (2019)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Towards a Pharmacophore for Amyloid
por: Landau, Meytal, et al.
Publicado: (2011)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d5k8ec2mtnmri2i2gusp4r8i88